Warning: call_user_func_array() [function.call-user-func-array]: First argument is expected to be a valid callback, '' was given in /home/content/50/8762750/html/wp-includes/class-wp-hook.php on line 298

October 17, 2013

October 17, 2013

We made two new recommendations in last week’s premium global market commentary.  Upgrade your subscription today to get these two new recommendations.  To upgrade your subscription click the following button.

 

upgrade.jpg

 


Global Economics Provides Reasons to Be Bullish, But Politics Poses Downside Risk

Despite headline-grabbing events in Washington, we remain bullish on a fundamental basis for U.S. and Japanese markets.  We continue to see an overall picture of low inflation, low interest rates, easy money from national banks, strong corporate profits, and good consumer and producer sentiment.  In the U.S., we see the wealth effect from housing and the winding down of the foreclosure crisis; in Japan we see the potential that Abenomics will still boost Japanese equities.  We also see positive data points beyond the U.S. and Japan that suggest a wider medium-term optimism is warranted.  China continues to show healthy growth and evidence of an economic rebalancing towards the consumer; Europe’s equities are attracting investor interest as Europe slowly emerges from crisis.  Some Asian economies show signs of recovering from the summer’s turmoil and benefitting from the wider global recovery, and in Latin America, Mexico is poised to benefit from structural reforms to the energy sector.

 


Headwinds for biotech? 

With some American jurisdictions approving the purchase of pharmaceuticals from overseas, we see near-term benefits and longer-term problems for the industry as the Affordable Care Act moves forward.  The legislation will give health-care access to more consumers.  But it may ultimately make it more difficult for pharma and biotech start-ups to recover their R & D costs if they face competition with government-controlled pharma prices from Canada or Europe.  The orphan drug space could be particularly hard-hit.


Guild Basic Needs IndexTM

July GBNI.jpg

Track our analysis in these letters and at www.gbni.info.


In Last Week’s Global Market Commentary We Discussed:

  • Should we still be bullish on Japan?
  • What about Venezuela?
  • Driverless Cars Aren’t Coming — They’re Here

Gold Subscribers have full access to all Premium content.  In addition, Gold Subscribers can participate on Guild’s periodic conference calls where participants can ask direct questions to acclaimed Guild’s portfolio managers and research team.  We will be announcing our conference call date and time in the coming weeks.  Please click the button below to learn about the benefits of Gold Subscription, or contact our office at (310) 826-8600.

 

upgrade.jpg


Guild Recommendation Tracker

Rec table image 100.jpg